Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".
Summary
H.J.Res.123 would nullify a CMS rule that tightened Marketplace enrollment integrity. The bill is early stage (referred to committee) but has a failed companion in the Senate. Market pricing in $CNC and $MOH has been extremely bullish (+63% and +46% over 30 days) based on broader momentum, not this legislative risk. If the resolution gains traction, it creates downside risk for pure-play ACA insurers.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.H.J.Res.123 nullifies CMS Marketplace Integrity rule; early stage with failed Senate companion
- 2.$CNC and $MOH have rallied 63% and 46% respectively in 30 days, not pricing in this legislative risk
- 3.Passage probability is low but non-zero; CRA expedited process creates binary event risk
- 4.Nullification increases adverse selection and administrative costs for ACA exchange insurers
Market Implications
Current pricing in $CNC ($53.38) and $MOH ($195.17) reflects strong 7-day and 30-day momentum (+27.6%/+11% and +63%/+46% respectively) that appears driven by sector-wide optimism rather than this specific legislative risk. The 52-week ranges ($25-$64 for CNC, $121-$333 for MOH) show both stocks well off lows but not at highs — suggesting room for further upside if positive catalysts (Medicaid unwinding stabilization, Medicare rate updates) materialize. The H.J.Res.123 bear case represents a 5-15% downside risk if the bill advances out of committee. The Senate companion failure (47-52) signals this is unlikely to pass, but the CRA mechanism means a single floor vote could revive it. Investors should monitor the Energy & Commerce committee mark-up schedule and any floor vote announcements. If the bill suddenly gains a markup date, expect immediate selling pressure in ACA-exposed names.
Full Analysis
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Nullification of CMS rule requiring annual open enrollment Nov 1–Dec 31, pre-enrollment verification for ≥75% of SEP enrollments, and DACA exclusion from exchanges/Basic Health Programs
Who must act
Insurers offering Qualified Health Plans on ACA exchanges, including Centene via its Ambetter subsidiary
What happens
Removal of enrollment window standardization and verification requirements increases adverse selection risk and administrative costs; DACA recipient enrollment expands risk pool but adds regulatory uncertainty
Stock impact
Centene is the largest ACA exchange insurer by enrollment (~4M lives in 2025). Nullification removes rule protections that helped stabilize premium pricing. Increased SEP gaming could raise medical loss ratios by 2-4 percentage points in the exchange segment, which accounts for ~25% of premium revenue
What the bill does
Same as above — nullification of CMS Marketplace Integrity rule affects all ACA exchange insurers
Who must act
Molina Healthcare's Marketplace segment offering plans in 15+ states
What happens
Removal of pre-enrollment verification requirements for SEPs and standardization of open enrollment period leads to higher administrative costs and potential adverse selection in Molina's exchange book
Stock impact
Molina's Marketplace segment represents ~20% of total premium revenue (~$3B of ~$15B total premiums in FY2025). Increased SEP utilization and adverse selection could reduce segment profitability by 3-5% annually. Molina's lower premium position relative to Centene leaves less margin buffer
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Association Health Plans Act
Medicare for All Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $895M Department of Veterans Affairs Contract
I CAN Act
SPREZZATURA MANAGEMENT CONSULTING, LLC: $23.2M Department of Veterans Affairs Contract
Putting Patients First Healthcare Freedom Act
To amend title XVIII of the Social Security Act to provide for certain reforms under the Medicare Advantage program, and for other purposes.
ANCHOR Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.